Future of EU medtech regs takes critical leap forward as trialogue now set for H2 2015
This article was originally published in Clinica
The overhaul of the EU medtech regulatory system has passed another important milestone after the Latvian Presidency of the Council of the European Union today reached an agreement on amendments to the European Commission’s proposed Medical Device and IVD Regulations.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies